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Sir, 20 
Worldwide, the Escherichia coli serotype O25b-sequence type (ST) 131 clonal group is 21 
emerging and represent an important cause of antimicrobial-resistant infections that ranges 22 
from uncomplicated cystitis to life-threatening bactaeremia.1 Nonetheless, there is only 23 
limited epidemiological information about this clonal group in Asia.1-3 In this study, we 24 
investigated the presence of this clonal group among 271 E. coli isolates recovered from a 25 
prospective cohort of female outpatients with uncomplicated cystitis in Hong Kong during 26 
2006-2008.4 The patient demographics and antimicrobial susceptibility of the isolates have 27 
previously been published.4 In brief, all patients had community-acquired infections. Prior 28 
urinary tract infection (UTI) history was present in 78 (28.8%) patients and 38 (14.0%) had 29 
been treated with antibiotics in the preceding six weeks.4 The major E. coli phylogenetic 30 
groups (A, B1, B2 and D) were determined by multiplex PCR.3,5 Subsequently, O25b-ST131 31 
isolates were identified by PCRs for the O25b-ST131-specific single nucleotide 32 
polymorphism in pabB and the O25b rfb variant.5,6  33 
The isolates were found to have the following phylogenetic group distribution: B2 34 
(66.9%, 181/271), D (17.7%, 48/271), A (10.3%, 28/271) and B1 (5.2%, 14/271). Twenty-35 
three of the B2 isolates were PCR positive for both pabB and O25b and were identified as 36 
O25b-ST131 isolates. All other isolates were PCR-negative for the two targets. Thus, O25b-37 
ST131 accounted for 8.5% (23/271) of the total E. coli population. The 23 isolates were 38 
recovered from patients with residence in 13 of the 18 geographic districts in Hong Kong. 39 
The O25b-131 clonal group accounted for the following proportions of E. coli infections in 40 
the different age groups: 18-35 years (4.3%, 3/71), 36-50 years (6.5%, 7/107), 51-64 years 41 
(9.3%, 5/54) and ≥65 years (20.5%, 8/39). The proportion of O25b-ST131 isolates in patients 42 
aged ≥65 years was significantly higher than that among patients aged 18-64 years (P = 43 
0.004). O25b-ST131 isolates were significantly more likely than non-O25b-ST131 isolates to 44 
be ciprofloxacin-resistant (69.6%, 16/23 vs. 7.7%, 19/248; P < 0.001), cotrimoxazole-45 
resistant (52.2%, 12/23 vs. 28.6%, 71/248; P = 0.02) and gentamicin-resistant (52.2%, 12/23 46 
vs. 14.9%, 37/248; P < 0.001). Table 1 showed that O25b-ST131 isolatesaccounted for 47 
45.7% and 41.7% of the ciprofloxacin-resistant, and dually ciprofloxacin and cotrimoxazole-48 
resistant E. coli populations, respectively. The incidence of O25b-ST131 among 49 
antimicrobial-susceptible (as defined by susceptibility to all of ciprofloxacin, cotrimoxazole 50 
and gentamicin) isolates was low (2.9%, 5/175). PCR and sequencing showed that the only 51 
ESBL-producing O25b-ST131 isolate had blaCTX-M-14.  52 
 Our results showed that O25b-ST131 exhibited a wide range of susceptibility patterns. 53 
Similar to previous studies,1,5 our findings showed that O25b-ST131 isolates were often 54 
multidrug-resistant and one was a CTX-M producer. However, the only ESBL-producing 55 
O25b-ST131 isolate was found to have blaCTX-M-14 instead of blaCTX-M-15.1,5 Among blood 56 
culture E. coli isolates collected in 2007-2008, our recent work showed that O25b-ST131 57 
accounted for 25.6% of the ESBL-producing isolates.3 All ESBL-producing O25b-ST131 58 
isolates had blaCTX-M-14 and none had blaCTX-M-15.3 As our previous studies revealed, the 59 
dissemination of blaCTX-M-14 in O25b-ST131 isolates was associated with the acquisition of an 60 
epidemic pHK01 plasmid with FII replicon.3  In conclusion, this study showed that the O25b-61 
ST131 clonal group is widely distributed among E. coli isolates causing community-acquired 62 
urinary tract infection in the region. The finding highlights the importance of clonal 63 
expansion in dissemination of antimicrobial resistance involving first-line drugs commonly 64 
used for treatment of urinary tract infections.  65 
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Table 1. Contribution of O25b-ST131 to antimicrobial-resistant E. coli populations, 2006-70 
2008 71 
Resistance phenotype % (number/total) of with 
phenotype 
Fraction due to O25b-ST131, % 
(number/subtotals) 
ESBL-positive 5.2 (14/271) 7.2 (1/14) 
Cip-R 12.9 (35/271) 45.7 (16/35) 
Sxt-R 30.6 (83/271) 14.4 (12/83) 
Gen-R 18.1 (49/271) 24.5 (12/49) 
Cip-R and Sxt-R 8.9 (24/271) 41.7 (10/24) 
Cip-S, Gen-S and Sxt-S 64.6 (175/271) 2.9 (5/175) 
Cip-R/S, ciprofloxacin-resistant/sensitive; Gen-R, gentamicin-resistant/sensitive; Sxt-R/R, 72 
cotrimoxazole-resistant/sensitive; ESBL, extended-spectrum β-lactamase 73 
74 
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